Mucosal Surveillance and Immunology of Respiratory Pathogens in South African Children Post the COVID-19 Pandemic

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The goal of this observational study is to answer a few questions about respiratory tract infections in South African children: 1. How do children with COVID-19 and other respiratory (chest, throat, ear or nose) germs show symptoms? What signs should be looked for, and which children are more likely to get seriously ill? Are there any new germs that haven't been discovered yet? Can immune cells in saliva predict which children will get more severe disease? 2. The body's immune response (soldier- cells) in blood and saliva (spit) will be studied. 3. What is the short-term effect of COVID-19 and other respiratory viruses/ germs on the breathing (lung function) of children? 4. What is the impact of respiratory germs on the quality of life in children and their families? The investigators aim to recruit a minimum of 250 children with respiratory pathogens.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 13
Healthy Volunteers: f
View:

• \- Children aged 0-13 years with acute respiratory tract infections presenting to Tygerberg Hospital (TBH) in Cape Town, South Africa, for routine care

Locations
Other Locations
South Africa
Desmond Tutu TB Centre
RECRUITING
Cape Town
Desmond Tutu TB Centre, Tygerberg Hospital
RECRUITING
Cape Town
Contact Information
Primary
Margaret van Niekerk, Masters (Human Nutrition)
mbunting@sun.ac.za
+27219389177
Backup
Michaile Mackriel, PhD
manthony@sun.ac.za
+27219389177
Time Frame
Start Date: 2024-10-23
Estimated Completion Date: 2025-11
Participants
Target number of participants: 250
Treatments
Acute RTIs
Children aged 0-13 years presenting with acute respiratory tract infections to Tygerberg Hospital.
Related Therapeutic Areas
Sponsors
Collaborators: European Union
Leads: Desmond Tutu TB Centre

This content was sourced from clinicaltrials.gov